CONMED Corporation (FRA:EC8)

CONMED Statistics

Total Valuation

CONMED has a market cap or net worth of EUR 1.19 billion. The enterprise value is 1.89 billion.

Market Cap	1.19B
Enterprise Value	1.89B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Sep 15, 2025

Share Statistics

Current Share Class	30.97M
Shares Outstanding	n/a
Shares Change (YoY)	-0.29%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	0.86%
Owned by Institutions (%)	113.83%
Float	30.68M

Valuation Ratios

The trailing PE ratio is 21.71 and the forward PE ratio is 9.59.

PE Ratio	21.71
Forward PE	9.59
PS Ratio	1.03
PB Ratio	1.38
P/TBV Ratio	n/a
P/FCF Ratio	9.34
P/OCF Ratio	8.29
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.34, with an EV/FCF ratio of 14.86.

EV / Earnings	34.54
EV / Sales	1.63
EV / EBITDA	9.34
EV / EBIT	14.26
EV / FCF	14.86

Financial Position

The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.85.

Current Ratio	2.10
Quick Ratio	0.84
Debt / Equity	0.85
Debt / EBITDA	3.64
Debt / FCF	5.73
Interest Coverage	4.72

Financial Efficiency

Return on equity (ROE) is 6.60% and return on invested capital (ROIC) is 5.15%.

Return on Equity (ROE)	6.60%
Return on Assets (ROA)	4.15%
Return on Invested Capital (ROIC)	5.15%
Return on Capital Employed (ROCE)	7.66%
Revenue Per Employee	294,474
Profits Per Employee	14,002
Employee Count	3,900
Asset Turnover	0.58
Inventory Turnover	1.66

Taxes

In the past 12 months, CONMED has paid 18.27 million in taxes.

Income Tax	18.27M
Effective Tax Rate	25.07%

Stock Price Statistics

The stock price has decreased by -46.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.57%
50-Day Moving Average	38.74
200-Day Moving Average	45.97
Relative Strength Index (RSI)	45.92
Average Volume (20 Days)	26

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.21

Income Statement

In the last 12 months, CONMED had revenue of EUR 1.15 billion and earned 54.61 million in profits. Earnings per share was 1.75.

Revenue	1.15B
Gross Profit	648.71M
Operating Income	131.10M
Pretax Income	72.88M
Net Income	54.61M
EBITDA	192.50M
EBIT	131.10M
Earnings Per Share (EPS)	1.75

Balance Sheet

The company has 33.18 million in cash and 727.65 million in debt, giving a net cash position of -694.47 million.

Cash & Cash Equivalents	33.18M
Total Debt	727.65M
Net Cash	-694.47M
Net Cash Per Share	n/a
Equity (Book Value)	859.34M
Book Value Per Share	27.76
Working Capital	296.14M

Cash Flow

In the last 12 months, operating cash flow was 142.92 million and capital expenditures -15.97 million, giving a free cash flow of 126.96 million.

Operating Cash Flow	142.92M
Capital Expenditures	-15.97M
Free Cash Flow	126.96M
FCF Per Share	n/a

Margins

Gross margin is 56.49%, with operating and profit margins of 11.42% and 4.75%.

Gross Margin	56.49%
Operating Margin	11.42%
Pretax Margin	6.35%
Profit Margin	4.75%
EBITDA Margin	16.76%
EBIT Margin	11.42%
FCF Margin	11.05%

Dividends & Yields

This stock pays an annual dividend of 0.72, which amounts to a dividend yield of 1.88%.

Dividend Per Share	0.72
Dividend Yield	1.88%
Dividend Growth (YoY)	-1.45%
Years of Dividend Growth	1
Payout Ratio	38.60%
Buyback Yield	0.29%
Shareholder Yield	2.16%
Earnings Yield	4.61%
FCF Yield	10.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CONMED has an Altman Z-Score of 2.17 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.17
Piotroski F-Score	7